Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
08/1995
08/09/1995EP0665852A1 Recombinant ctla4 polypeptides and methods for making the same
08/09/1995EP0665851A1 Method for isolating immunoglobulin compounds in the feces
08/09/1995EP0665850A1 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions
08/09/1995EP0535007B1 A MONOCLONAL ANTIBODY AGAINST THE GAG PROTEIN PRECURSOR p55 OF HUMAN IMMUNODEFICIENCY VIRUS
08/09/1995CN1106461A Method for prepn. of colony stimulating factor
08/09/1995CN1106414A Method for extracting protein and polysaccharide from spiral algae and its use
08/08/1995US5440019 Processes of producing amylase inhibitors
08/08/1995US5440018 Ultrfiltration, acidd treating, ion exchanging, purifying
08/08/1995US5440013 Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
08/08/1995US5440012 Excellent blood calcium-decreasing activity and chondrocyte differentiating-promoting activity
08/08/1995US5439887 Peptide having antihypertensive activity free of vascoconstrictor activity
08/08/1995US5439829 Bonding chelating agent to biologically active molecule on a support, treating with oxidizing or reducing agent to change oxidation state of chelating metal ion and immobilize active molecule on the support
08/08/1995US5439825 Analysis of hemoglobin variants by capillary zone electrophoresis
08/08/1995US5439808 Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
08/08/1995US5439807 Methods for the preparation of endotoxin-binding proteins
08/08/1995US5439806 Carboxylate protective groups, a process for their preparation, their coupling to a functional group, and their use
08/08/1995US5439795 Cystine residue linked to glycine residue at the end of carboxy terminus of peptide; animal growth regulator
08/08/1995US5439792 Cysteine thiol-protected peptides for use in immunoassays
08/08/1995US5439591 Feeding crude hemoglobin solution to column under anionic exchange conditions to bind more acidic components until column is overloaded and hemoglobin is displaced, feeding eluent to cationic column to bind more basic components
08/03/1995WO1995020764A1 Specific binding substances for antibodies and their use for immunoassays or vaccines
08/03/1995WO1995020661A1 Materials and methods for management of hyperacute rejection in human xenotransplantation
08/03/1995WO1995020602A2 ANALOGS OF THYMOSIN α¿1?
08/03/1995WO1995018823A3 Substrate specificity of protein kinases
08/03/1995WO1995014038A3 Purification of hemoglobin
08/03/1995DE4402756A1 Spezifische Bindungssubstanzen für Antikörper und deren Verwendung für Immunoassays oder Vakzine Specific binding substances for antibodies and their use for immunoassays or vaccine
08/03/1995CA2141642A1 Thrombocyte-stabilizing factor ix-fragments, their preparation and use and drugs containing these
08/02/1995EP0665215A1 1,4-Diamino-2,3-dihydroxybutanes
08/02/1995EP0664884A1 Method and product for the sequence determination of peptides using a mass spectrometer
08/02/1995CN1106021A Method for the separation of bacterial lipopolysaccharides from protein-containing solutions
08/02/1995CN1106019A Production technology of crude cytochrome C
08/01/1995US5438119 Preferential binding of peptide having desired activity or receptivity, then separation from mixed peptides
08/01/1995US5438118 Peptide mimics having constrained peptide backbone
08/01/1995US5438040 Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
08/01/1995US5437986 Ferementing bacteria in broth, disrupting and cooling; adding acid and incubating to inactivate bacteria to inhibit emission of live bacteria while centrifuging; increased purity
08/01/1995US5437774 High molecular weight electrodialysis
08/01/1995CA1336530C Human serum albumin crystals and method of preparation
08/01/1995CA1336528C Antimalarial amnioquinoline derivatives, process for their preparation and pharmaceutical composition containing them
08/01/1995CA1336497C Immunoconjugates for cancer diagnosis and therapy
07/1995
07/27/1995WO1995020162A1 Peptomers with enhanced immunogenicity
07/27/1995WO1995020156A1 On line ion contaminant removal apparatus and method for capillary electrophoresis
07/27/1995WO1995019791A1 Radiolabeled annexins
07/26/1995EP0663925A1 Affinity purification methods involving amino acid mimetics as elution reagents
07/26/1995EP0663856A1 Apparatus and method for multiple simultaneous synthesis
07/26/1995EP0596929B1 Amide derivatives of antibiotic a 40926
07/26/1995EP0516833B1 Use of zwitterions to mobilize isoelectrically focused ampholyte zones
07/26/1995CN1105800A Selective crosslinking of hemoglobins by oxidized, ring-opened saccharides
07/26/1995CN1105670A Human embryo collagen and preparing method thereof
07/25/1995US5436850 Method to identify protein sequences that fold into a known three-dimensional structure
07/25/1995US5436157 Human intra-acrosomal sperm antigen
07/25/1995CA1336404C General cancer-associated scm-recognition factor, preparation and method of use
07/20/1995WO1995019603A1 Method for determining protein tertiary structure
07/20/1995WO1995019568A1 Hydrophilic signal oligopeptides and methods of therapeutic use
07/20/1995WO1995019567A1 Synthetic receptors, libraries and uses thereof
07/20/1995WO1995019370A1 Ion-channel forming amphiphilic peptides having n-terminal modifications
07/20/1995WO1995019339A1 Biomolecule solubilisation agents consisting of non-detergent zwitterions, and uses thereof
07/20/1995WO1995015335A3 Pretargeting methods and compounds
07/20/1995CA2180844A1 Synthetic receptors, libraries and uses thereof
07/20/1995CA2180748A1 Ion-channel forming amphiphilic peptides having n-terminal modifications
07/19/1995EP0663407A1 Process for preparation of reconstituted lipoproteins
07/19/1995EP0663406A1 VIP analog
07/19/1995EP0663009A1 High molecular weight desulphatohirudin
07/19/1995EP0638168A4 Capillary electrophoresis molecular weight separation of biomolecules using a polymer-containing solution.
07/19/1995EP0506846B1 Amino acid thiohydantoin method and reagent
07/19/1995EP0424416B1 Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex
07/19/1995EP0198015B2 Production of streptavidin-like polypeptides
07/18/1995US5434796 Method and apparatus for designing molecules with desired properties by evolving successive populations
07/18/1995US5434250 Process for manufacturing high α-lactalbumin content composition
07/18/1995US5434245 Osteocalcin
07/18/1995US5434135 Growth factor compositions, preparation and use
07/18/1995US5434077 Borrelia burgdorferi strain 257
07/18/1995US5434067 Process for the production and renaturation of recombinant, biologically active, eukaryotic alkaline phosphatase
07/18/1995US5434064 Expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins
07/18/1995CA1336349C Nitrogenous polycyclic tripeptides, their preparation and pharmaceutical compositions containing them
07/18/1995CA1336348C Process for industrial synthesis of perindopril and its major synthesis intermediates
07/18/1995CA1336329C Fusion proteins, a process for their preparation and their use
07/13/1995WO1995018971A1 Methods for the solid phase synthesis of glycoconjugates
07/13/1995WO1995018868A1 Random oligonucleotide libraries and methods of making the same
07/13/1995WO1995018825A1 Novel bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis
07/13/1995WO1995018823A2 Substrate specificity of protein kinases
07/13/1995WO1995018781A1 Methods for synthesizing oligomers containing hydroxy acid units
07/13/1995WO1995018627A1 Method of making polymers having specific properties
07/13/1995CA2180644A1 Novel bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis
07/12/1995EP0662513A1 Methods for preventing degradation of protein C
07/12/1995EP0662482A1 Process for preparation of human glicentin
07/12/1995EP0662481A1 Spiro piperidines and homologs promote release of growth hormone
07/12/1995EP0662092A1 Activity-dependent neurotrophic factor
07/12/1995EP0662088A1 Inhibitor of collagen-stimulated platelet aggregation
07/12/1995EP0662087A1 Retinal pigmented epithelium derived neurotrophic factor
07/12/1995EP0662081A1 Ureido-acetamide derivatives, preparation thereof and drugs containing same.
07/12/1995EP0662079A1 Alpha-helix mimetics and methods relating thereto
07/12/1995EP0662078A1 New reagents for peptide couplings
07/12/1995EP0661999A1 Anti-feline immunodeficiency virus (fiv) vaccines
07/12/1995EP0661996A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses
07/12/1995CN2203301Y Apparatus for purifying and concentrating protein
07/12/1995CN1105029A Process for producing solubilized protein
07/11/1995US5432263 Process for producing peptides with side chains containing imidazolinylamino, tetrahydropyrimidinylamino, or alkylguanidinyl groups
07/11/1995US5432262 Method of purifying α-L-aspartyl-L-phenylalanine methyl ester
07/11/1995US5432159 N-(α-substituted-pyridinyl)carbonyl dipeptide antihypertensive agents
07/11/1995US5432157 Chrysospermins, active peptides from apiocrea chrysosperma having a pharmacological effect and a use thereof
07/11/1995US5432093 Sequential degradation of proteins and peptides from the N-terminus